Up-regulation of Fas (CD95) expression in tumour cells in vivo

Immunology

Volumn 120, Issue 4, 2007, Pages 502-511

  Peshes Yaloz, Naama ^a   Rosen, Dalia ^a   Sondel, Paul M ^b   Krammer, Peter H ^c   Berke, Gideon ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF WISCONSIN   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Fas; Mice; Nitric oxide; Tumour

Indexed keywords

FAS ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; ASCITES; ASCITES FLUID; CELL CULTURE; CONTROLLED STUDY; HOST RESISTANCE; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPLEEN CELL; TUMOR CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD95; ANTIGENS, NEOPLASM; APOPTOSIS; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; UP-REGULATION;

EID: 33847682187     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02521.x     Document Type: Article

References (60)

1. Kishi S, Kurasawa K, Hashimoto Y, Iwamoto I. [Programmed thymic T cell death and negative selection via Fas and TCR/CD3 complex] Fas modulates both positive and negative selection of thymocytes. Nippon Rinsho 1996; 54:1760-7.
2. Krammer PH. CD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 1999; 71:163-210.
3. Lynch DH, Campbell KA, Miller RE, Badley AD, Paya CV. FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease. Behring Inst Mitt 1996; 97:175-84.
4. Sejima T, Miyagawa I. Significance of Fas expression alteration during tumor progression of renal cell carcinoma. Int J Urol 2006; 13:257-64.
5. Eser B, Sari I, Canoz O et al. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. Am J Hematol 2006; 81:307-14.
6. Buhling F, Wille A, Rocken C, Wiesner O, Baier A, Meinecke I, Welte T, Pap T. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis. Respir Res 2005; 6:37.
7. Peter ME, Legembre P, Barnhart BC. Does CD95 have tumor promoting activities? Biochim Biophys Acta 2005, 1755; 1:25-36.
8. Muller M, Wilder S, Bannasch D et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998; 188:2033-45.
9. Bhushan A, Kupperman JL, Stone JE et al. Drug resistance results in alterations in expression of immune recognition molecules and failure to express Fas (CD95). Immunol Cell Biol 1998; 76:350-6.
10. Kamihira S, Yamada Y, Tomonaga M, Sugahara K, Tsuruda K. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: soluble Fas isoform is an independent risk factor for prognosis. Br J Haematol 1999; 107:851-60.
11. Waring P, Mullbacher A. Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 1999; 77:312-7.
12. Booker JK, Reap EA, Cohen PL. Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice. J Immunol 1998; 161:4536-41.
13. Bian X, Giordano TD, Lin HJ, Solomon G, Castle VP, Opipari AW Jr. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation. J Biol Chem 2004; 279:4663-9.
14. Kimura M, Haisa M, Uetsuka H et al. TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells. Cell Death Differ 2003; 10:718-28.
15. Moulian N, Bidault J, Planche C, Berrih-Aknin S. Two signaling pathways can increase fas expression in human thymocytes. Blood 1998; 92:1297-307.
16. Trifilieff A, Futjitani Y, Coyle AJ, Bertrand C. Fas-induced death of a murine pulmonary epithelial cell line: modulation by inflammatory cytokines. Fundam Clin Pharmacol 1999; 13:656-61.
17. Choi C, Park JY, Lee J et al. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol 1999; 162:1889-95.
18. Garban HJ, Bonavida B. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecol Oncol 1999; 73:257-64.
19. Garban HJ, Bonavida B. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J Immunol 2001; 167:75-81.
20. Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC, Wogan GN. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res 2004; 64:3022-9.
21. Vekemans K, Braet F, Muyllaert D, Wisse E. Nitric oxide from rat liver sinusoidal endothelial cells induces apoptosis in IFN gamma-sensitized CC531s colon carcinoma cells. J Hepatol 2004; 41:11-8.
22. Rosen D, Li JH, Keidar S, Markon I, Orda R, Berke G. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1). J Immunol 2000; 164:3229-35.
23. Screpanti V, Wallin RP, Ljunggren HG, Grandien A. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J Immunol 2001; 167:2068-73.
24. Simon MM, Waring P, Lobigs M, Nil A, Tran T, Hla RT, Chin S, Mullbacher A. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis. J Immunol 2000; 165:3663-72.
25. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265:528-30.
26. Lapidot T, Kollet O. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m (null) mice. Leukemia 2002; 16:1992-2003.
27. Rouvier E, Luciani MF, Golstein P. Fas involvement in Ca (2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177:195-200.
28. Walsh CM, Matloubian M, Liu CC et al. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A 1994; 91:10854-8.
29. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989; 7:601-24.
30. Matza D, Lantner F, Bogoch Y, Flaishon L, Hershkoviz R, Shachar I. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc Natl Acad Sci USA 2002; 99:3018-23.
31. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998; 187:1205-13.
32. Fehsel K, Kroncke KD, Kolb-Bachofen V. Assay for detection of nitric oxide-induced apoptosis. Methods Enzymol 1996; 269:426-34.
33. Chandra D, Choy G, Deng X, Bhatia B, Daniel P, Tang DG. Association of active caspase 8 with the mitochondrial membrane during apoptosis. potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Mol Cell Biol 2004; 24:6592-607.
34. Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L, Marcelli M. Overexpression of BCL-X (L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 2001; 61:1699-706.
35. Legembre P, Schickel R, Barnhart BC, Peter ME. Identification of SNF1/AMP kinase-related kinase as an NF-{kappa}B-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness. J Biol Chem 2004; 279:46742-7.
36. Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003; 14:53-66.
37. Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 2003; 170:6338-47.
38. Wallin RP, Screpanti V, Michaelsson J, Grandien A, Ljunggren HG. Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 2003; 33:2727-35.
39. Spanaus KS, Schlapbach R, Fontana A. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 1998; 28:4398-408.
40. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11:237-44.
41. Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. J Immunol 2003; 171:5244-54.
42. Shibaki A, Katz SI. Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells. Eur J Immunol 2001; 31:3006-15.
43. Fujii K, Fujii Y, Hubscher S, Tanaka Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J Immunol 2001; 167:1198-203.
44. Esaki T, Hayashi T, Muto E, Kano H, Kumar TN, Asai Y, Sumi D, Iguchi A. Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide 2000; 4:561-71.
45. Feng S, Bogatcheva NV, Kamat AA, Truong A, Agoulnik AI. Endocrine effects of relaxin overexpression in mice. Endocrinology 2006; 147:407-14.
46. Sinha P, Sengupta J, Ray PK. A minimized Fc binding peptide from protein A induces immunocyte proliferation and evokes Th1-type response in mice. Biochem Biophys Res Commun 1999; 258:141-7.
47. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide. evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218:739-49.
48. Zheng Y, Ouaaz F, Bruzzo P, Singh V, Gerondakis S, Beg AA. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J Immunol 2001; 166:4949-57.
49. Lincoln J, Hoyle CHV, Burnstock G. Nitric Oxide in Health and Disease. Cambridge: University Press, 1997.
50. Jaffrey SR, Snyder SH. Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol 1995; 11:417-40.
51. Heigold S, Sers C, Bechtel W, Ivanovas B, Schafer R, Bauer G. Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts. Carcinogenesis 2002; 23:929-41.
52. Curtin JF, Cotter TG. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 2003; 15:983-92.
53. Mitsiades CS, Poulaki V, Fanourakis G et al. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res 2006; 12:3705-12.
54. Park IC, Woo SH, Park MJ et al. Ionizing radiation and nitric oxide donor sensitize Fas-induced apoptosis via up-regulation of Fas in human cervical cancer cells. Oncol Rep 2003; 10:629-33.
55. Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J, Kay TW. IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 2004; 53:113-21.
56. Arnold R, Seifert M, Asadullah K, Volk HD. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 1999; 162:7140-7.
57. Wang X, Zalcenstein A, Oren M. Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation. Cell Death Differ 2003; 10:468-76.
58. Ivanov VN, Fodstad O, Ronai Z. Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFalpha and suppression of NF-kappaB activities. Oncogene 2001; 20:2243-53.
59. Ivanov VN, Krasilnikov M, Ronai Z. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling. J Biol Chem 2002; 277:4932-44.
60. YuZ, Zhang W, Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J 2002; 367:97-105.